InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Scott John K Jr., Director. Director active across 1 company, notably Navidea Biopharmaceuticals, INC.. Cumulatively, 10 filings have been published. Activity tracked since 15 November 2021. The latest transaction was filed on 31 May 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
2,500 shares0Common StockSEC:0001437749-22-014045:0
2,500 shares0Common StockSEC:0001437749-22-010726:0
2,500 shares0Common StockSEC:0001437749-22-007860:0
2,500 shares0Common StockSEC:0001437749-22-004850:0
2,500 shares0Common StockSEC:0001437749-22-002110
2,500 shares0Common StockSEC:0001437749-22-002110:0
2,500 shares0Common StockSEC:0001437749-22-000324
2,500 shares0Common StockSEC:0001437749-22-000324:0
30,000 shares@ US$0.00150.0% of flowCommon StockSEC:0001437749-21-027696:0
30,000 shares@ US$0.001100.0% of flowCommon StockSEC:0001437749-21-027696
10 of 10 declarations
About Scott John K Jr.
John K. Scott Jr. is a Board Member at NAVIDEA BIOPHARMACEUTICALS, INC. As a board member, he contributes to the strategic direction of the company. His experience in the biopharmaceutical sector is valuable in guiding decisions and ensuring regulatory compliance. He plays an active role in evaluating the company's performance and overseeing its operations.
